FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

442699004: Tapentadol hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2009. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2818852010 Tapentadol hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2818853017 Tapentadol hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
843691000172112 chlorhydrate de tapentadol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tapentadol hydrochloride Is a Tapentadol false Inferred relationship Some
Tapentadol hydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Norepinephrine reuptake inhibitor (disposition) true Inferred relationship Some
Tapentadol hydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Opioid receptor agonist (disposition) true Inferred relationship Some
Tapentadol hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Tapentadol true Inferred relationship Some
Tapentadol hydrochloride Is a Aromatic hydrocarbon true Inferred relationship Some
Tapentadol hydrochloride Is a Noradrenaline reuptake inhibitor true Inferred relationship Some
Tapentadol hydrochloride Is a Psychotropic agent (substance) true Inferred relationship Some
Tapentadol hydrochloride Is a Opioid receptor agonist true Inferred relationship Some
Tapentadol hydrochloride Is a Central depressant true Inferred relationship Some
Tapentadol hydrochloride Is a Analgesic (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely tapentadol (as tapentadol hydrochloride) 75 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tapentadol hydrochloride Inferred relationship Some
Product containing tapentadol hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tapentadol hydrochloride Inferred relationship Some
Tapentadol (as tapentadol hydrochloride) 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tapentadol hydrochloride Inferred relationship Some
Product containing precisely tapentadol hydrochloride 100 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tapentadol hydrochloride Inferred relationship Some
Product containing precisely tapentadol (as tapentadol hydrochloride) 75 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tapentadol hydrochloride Inferred relationship Some 1
Product containing precisely tapentadol hydrochloride 100 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tapentadol hydrochloride Inferred relationship Some 1
Product containing precisely tapentadol hydrochloride 100 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Tapentadol hydrochloride Inferred relationship Some 1
Tapentadol (as tapentadol hydrochloride) 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tapentadol hydrochloride Inferred relationship Some 1
Product containing precisely tapentadol (as tapentadol hydrochloride) 75 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tapentadol hydrochloride Inferred relationship Some 1
Tapentadol (as tapentadol hydrochloride) 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tapentadol hydrochloride Inferred relationship Some 1
Product containing precisely tapentadol hydrochloride 100 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Tapentadol hydrochloride Inferred relationship Some 1
Product containing precisely tapentadol (as tapentadol hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tapentadol hydrochloride Inferred relationship Some 1
Product containing precisely tapentadol (as tapentadol hydrochloride) 50 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tapentadol hydrochloride Inferred relationship Some 1
Product containing precisely tapentadol (as tapentadol hydrochloride) 150 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tapentadol hydrochloride Inferred relationship Some 1
Tapentadol (as tapentadol hydrochloride) 100 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tapentadol hydrochloride Inferred relationship Some 1
Product containing precisely tapentadol (as tapentadol hydrochloride) 250 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tapentadol hydrochloride Inferred relationship Some 1
Product containing precisely tapentadol (as tapentadol hydrochloride) 200 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tapentadol hydrochloride Inferred relationship Some 1
Product containing precisely tapentadol (as tapentadol hydrochloride) 4 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tapentadol hydrochloride Inferred relationship Some 1
Tapentadol (as tapentadol hydrochloride) 20 mg/mL oral solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tapentadol hydrochloride Inferred relationship Some 1

This concept is not in any reference sets

Back to Start